JAN 04, 2017 6:30 PM PST

Scientists Unveil Unique Factors Contributing to Autoimmune Disease

WRITTEN BY: Kara Marker

Many autoimmune diseases come in waves, where symptoms temporarily get worse followed by a time of little to no signs of disease. There are a lot of factors that govern why and how an autoimmune disorder occurs, but a recent study was focused specifically on the quality of autoimmunity that causes flare-ups of disease. The same study ultimately resulted in the revealing of two key factors involved in this process, providing doctors and patients new hope for an autoimmune treatment.

Source: OnlineHealth.wiki

From the Schepens Eye Research Institute of Massachusetts Eye and Ear Infirmary, researchers focused on a mouse model of dry eye disease, an autoimmune disease that shares molecular similarities with multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease, and another chronic inflammatory eye disorder called uveitis. The common denominator is Th17 cells, which can continue living in the circulation for a relatively long time as memory cells.

They quickly identified interleukins (IL) 7 and 15, immune cytokines secreted by other immune cells that act as cell-signaling proteins. IL-7 and IL-15 play the role of memory regulation for Th17 cells, the researchers discovered. This enlightenment meant two new targets for treatments.

"By selectively targeting the production and expression of IL-7 and IL-15, we may be able to prevent the development of chronic autoimmune disorders,” explained senior author Reza Dana, MD, Msc, MPH. Dana’s study is the first to uncover how Th17 cells maintain memory.

During the study, when scientists neutralized IL-7 and IL-15, the result was a significant decrease in the number of memory Th17 cells, further highlighting the potential for the two interleukins as targets for a new autoimmune disease treatment.

"In the case of dry eye disease, many of the treatments are showing limited efficacy in patients that do not have a highly inflamed eye," Dana said. "Targeting the chronic, immune nature of autoimmune diseases may be a better strategy for controlling these conditions."

Dana’s study was recently published in the Journal of Autoimmunity.

Source: Massachusetts Eye and Ear Infirmary

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
AUG 04, 2019
Immunology
AUG 04, 2019
New Research In Reversing Deafness
Hair cells inside the human ear are responsible for sensing and relaying sound to the brain.  In all mammals except humans, these cells can regenerate...
SEP 29, 2019
Drug Discovery & Development
SEP 29, 2019
Researchers Can Now Reverse Skin Cancer
Ten years ago, just 5% of people with advanced melanoma (skin cancer) lived more than five years after being diagnosed. Now however, researchers from the I...
OCT 13, 2019
Microbiology
OCT 13, 2019
Molecule in Human Breast Milk Can Fight Microbial Pathogens
Now a team of scientists has found a molecule in human breast milk that may reduce the risk of illness and disease....
NOV 20, 2019
Health & Medicine
NOV 20, 2019
Could your bedding make you sick?
Do you use duvets or pillows filled with goose or duck feathers? While indeed cozy, doctors have issued a new warning related to feather filled bedding cal...
NOV 27, 2019
Genetics & Genomics
NOV 27, 2019
Humans Are Continuing to Evolve, Along With Immune-Related Diseases
Humans have evolved in some ways to be less susceptible to pathogens, but those benefits can also carry risks of other diseases....
FEB 17, 2020
Immunology
FEB 17, 2020
Another HIV vaccine attempt fizzles out
Years of work and over $100 million in study costs have been abandoned after an HIV-vaccine tested in South Africa failed to protect treated individuals ag...
Loading Comments...